rosacea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients aged 18-60 (not including 18 including 60 regardless of gender). (2)Meet the diagnostic criteria of erythematotelangiectatic rosacea and CEA score = 2. (3)Can comply with the research or follow-up process can cooperate to observe adverse events and efficacy.
Exclusion criteria
Exclusion criteria: (1) Apular pustular ocular nasal rosacea subjects. (2) Participated in any clinical study of any research drug within 1 month prior to enrollment. (3) Drugs that affect the symptoms of rosacea are being used such as psychoneurotic drugs such as carvedilol gabapentin and duloxetine as well as drugs that affect the condition of rosacea such as minocycline hydrochloride and isotretinoin. (4) Patients with bradycardia or severe heart liver lung kidney and other important organ lesions and hematopoietic system diseases that researchers believe are not suitable for clinical trials. (5) Subjects with malignant tumors systemic failure or low immune function. (6) Patients with facial acne atopic dermatitis hormone-dependent dermatitis and other facial skin-related diseases. (7) Subjects with a history of epilepsy and family history of epilepsy and tic disorder and other mental and neurological disorders who could not cooperate. (8) Acupuncture treatment taboo afraid of pricking needle afraid of pain. (9) Auricular skin abscess infection ulceration edema scar or allergy to desensitizing tape. (10) The outer ear cartilage suffering from multiple cartilage inflammation nodules and other lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinicians Erythema Assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Self-Assessment;Pittsburgh Sleep Quality Index;Global Flushing Severity Scale;Hamilton depression rating scale;Visual analog scale for migraine;Hamilton anxiety scale; | — |
Countries
China
Contacts
The First Affiliated Hospital of Army Medical University